SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-172087
Filing Date
2017-05-16
Accepted
2017-05-16 16:08:04
Documents
4
Period of Report
2017-05-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d400427d8k.htm 8-K 28492
2 EX-4.1 d400427dex41.htm EX-4.1 543160
3 EX-99.1 d400427dex991.htm EX-99.1 7243
4 GRAPHIC g400427g09p93.jpg GRAPHIC 2871
  Complete submission text file 0001193125-17-172087.txt   584344
Mailing Address 275 MIDDLEFIELD ROAD SUITE 150 MENLO PARK CA 94025
Business Address 275 MIDDLEFIELD ROAD SUITE 150 MENLO PARK CA 94025 650 421 7200
Dermira, Inc. (Filer) CIK: 0001557883 (see all company filings)

IRS No.: 273267680 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36668 | Film No.: 17848659
SIC: 2834 Pharmaceutical Preparations